The new mobile lab, expected to pay for itself within the first year, will travel between UCLA hospitals to sterilize surgical instruments

LOS ANGELESNov. 12, 2019 /PRNewswire/ -- Leading the market in mobile medical vehicles, Winnebago Industries, Inc. (NYSE: WGO) announced the delivery of the first all-electric mobile surgical instrument lab (eMSIL) to University of California at Los Angeles (UCLA) Health Center. The zero-emission mobile medical unit will travel between UCLA'sRonald Reagan and Santa Monica campuses to collect, clean, repair, disinfect and sterilize surgical suite instruments. The eMSIL joins other mobile medical initiatives at UCLA Health including a Mobile Stroke Unit, a Mobile Eye Clinic, and the Mobile Clinic Project serving homeless and low-income individuals.

Built by Winnebago and Motiv Power Systems, the zero-emission vehicle is expected to save the health center $750,000 a year, traveling between two hospitals to clean and sterilize surgical equipment, compared to contracting with an off-site, third-party provider to do the work.

"We've been told the vehicle is expected to save UCLA Health Center close to $750,000 a year compared to contracting with a third-party to service surgical instruments off-site. That adds significant value to the system's bottom line," said Ashis Bhattacharya Winnebago's Vice President of Business Development, Specialty Vehicles, and Advanced Technology. "We applaud UCLA for its innovative application of a mobile medical unit to transform a critical and costly service, normally fixed in a building, into one that can be transported to any location. The mobile medical market is a growing industry, with countless applications, from cancer screenings and primary care to opioid treatment and dental services. The variety of services these vehicles can deliver to communities is limited only by the imagination."

As a mobile unit, the eMSIL is a turnkey solution for receiving, decontaminating, preparing, packaging, sterilizing and distributing nearly any type of surgical equipment hospitals use. It was built by Winnebago Specialty Vehicles and one of its preferred commercial EV platform upfitters Summit Bodyworks. The eMSIL is powered by an all-electric EPIC F-53 33 foot chassis from Motiv Power Systems.

The eMSIL is designed to hold enough battery charge for eight hours of typical service plus round-trip travel to and from its home facility. For the eMSIL, this is more than enough capacity, considering the distance between the two hospitals. The vehicle has completed significant road testing and delivers an expected range of 85 to 125 miles on a full charge. Like all specialty vehicles, the eMSIL is eligible for service at more than 300 Winnebago locations across the U.S.

The eMSIL includes all the equipment needed to deliver the same level of performance, productivity and compliance from decontamination through sterilization as a lab located in a building. The vehicle upfit includes two desks in the slide-out area, two workbenches, an industrial sink and two stations for 5.5 gallon ultrasonic cleaners, among other custom cabinetry and equipment.

A portion of the funds used to purchase of the UCLA eMSIL were provided by the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP), a California Air Resources Board (CARB) program administered by clean transportation accelerator CALSTART and funded with cap-and-trade proceeds through California Climate Investments (CCI). HVIP cuts air pollution and greenhouse gas emissions while accelerating the development and commercialization of clean transportation technologies.  

"Now in its tenth year, HVIP has provided purchase discounts for more than 7,000 trucks and buses including zero-emission, hybrid, and low NOx natural gas technologies for users as varied as transit agencies, port support services and leading medical centers like UCLA," said Bill Van Amburg, Executive Vice President of CALSTART and head of the organization's work in on- and off-road technologies. "This mobile medical unit demonstrates the variety of vehicles types now becoming available, and how zero-emission vehicles can provide innovative capabilities, make an attractive business case and enhance the communities where they operate by eliminating tailpipe emissions while bringing needed services." 

The eMSIL is based on the standard Winnebago J33SE all-electric commercial shell platform, which earlier this year, won a Sustainability Award by the RV Industry Association (RVIA) for its efforts in bringing an all-electric option to this vehicle segment. 

About Winnebago Industries
Winnebago Industries, Inc. is a leading U.S. manufacturer of outdoor lifestyle products and commercial vehicles under the Winnebago, Grand Design and Chris-Craft brands, which are used primarily in leisure travel and outdoor recreation activities. The company builds quality motorhomes, travel trailers, fifth wheel products, boats, and commercial community outreach vehicles. Since the 1960s, its Specialty Vehicles division has leveraged the Winnebago motorhome platform to design and build custom community outreach vehicles for customers around the world. With flexible floorplans and chassis options to suit different budgets and sustainability goals, Winnebago commercial shells are ideal for applications such as mobile medical and dental services, DUI/BAT, cancer and preventive screenings, food trucks, event marketing, bloodmobiles, classrooms, bookmobiles, and many other applications. Winnebago Industries has multiple facilities in IowaIndianaMinnesota, and Florida. The Company's common stock is listed on the New York Stock Exchange and traded under the symbol WGO. For access to Winnebago Industries' investor relations material or to add your name to an automatic email list for Company news releases, visit

For more information about Winnebago Specialty Vehicles, please visit or follow on InstagramFacebookLinkedIn and Twitter

Technica Communications for Winnebago
Sarah Malpeli
[email protected]


User commented on October 18, 2021 12:20 PM
User commented on October 18, 2021 12:21 PM
1 commented on March 29, 2022 3:01 PM
1 commented on March 29, 2022 3:01 PM
1 commented on March 29, 2022 3:01 PM
1 commented on March 29, 2022 3:01 PM